Henan Lingrui Pharmaceutical Co., Ltd. operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Henan Lingrui Pharmaceutical Co., Ltd. with three other
companies in this sector in China:
Tianjin Tianyao Pharmaceutical, Ltd.
sales of 1.97 billion Chinese Renmimbi [US$284.18 million]
Hainan Haiyao Company Limited
(1.82 billion Chinese Renmimbi [US$262.97 million]
of which 77%
was BPC), and
Zhejiang Jiuzhou Pharmaceutical Co Ltd
(1.72 billion Chinese Renmimbi [US$247.53 million]
of which 92%
was Production and sale of chemical active p).
Henan Lingrui Pharmaceutical Co., Ltd. reported sales of 1.85 billion Chinese Renmimbi (US$266.43 million)
December of 2017.
increase of 28.5%
versus 2016, when the company's sales were 1.44 billion Chinese Renmimbi.
Sales at Henan Lingrui Pharmaceutical Co., Ltd. have increased during each of the previous five years
(and since 2012, sales have increased a total of 229%).
Sales of Healthcare saw an increase
28.5% in 2017, from
1.42 billion Chinese Renmimbi to 1.83 billion Chinese Renmimbi.
Not all segments of Henan Lingrui Pharmaceutical Co., Ltd. experienced an increase in sales in 2017:
sales of Other fell 24.9% to 23.02 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).